Keyphrases
Therapeutic Window
100%
Functional Outcome
100%
Traumatic Brain Injury
100%
D-cycloserine
100%
N-methyl-D-aspartate Receptor (NMDAR)
83%
Receptor Antagonist
33%
Protective Effect
16%
Infarct Volume
16%
Trauma
16%
Mechanism of Action
16%
Male Mice
16%
Brain Injury
16%
Neurobehavior
16%
Hyperactivity
16%
Dosing Regimen
16%
Functional Recovery
16%
Neurological Severity Score
16%
2,3,5-triphenyltetrazolium Chloride
16%
Additional Dose
16%
Partial Agonist
16%
Human Traumatic Brain Injury
16%
Neurological Deterioration
16%
Neurobehavioral Function
16%
MK-801
16%
All Clinical Trials
16%
Cresyl Violet
16%
Weight Drop Model
16%
Pharmacology, Toxicology and Pharmaceutical Science
Therapeutic Window
100%
Traumatic Brain Injury
100%
Cycloserine
100%
Dextro Aspartic Acid
83%
Receptor
50%
Injury
33%
Receptor Antagonist
33%
Infarction
16%
Clinical Trial
16%
Triphenyltetrazolium
16%
Partial Agonist
16%
Brain Injury
16%
Neuroscience
Neurotrauma
100%
Traumatic Brain Injury
100%
Cycloserine
100%
Dextro Aspartic Acid
83%
Receptor
50%
Receptor Antagonist
33%
Staining Technique
16%
Receptor Partial Agonist
16%
Cresyl Violet
16%